This outcome is achieved not only by the antioxidant effect of NRF2, but also because NRF2 collaborates with several different oncogenic pathways, sometime interconnected and/or that act in a feedback loop with NRF2, leading cancer cells to adapt to stresses induced, for instance, by anticancer therapies [44,45]. This evidence concerns the gene NFE2L2 and cancer.